Gloria Ying (06821) issued an announcement that Gloria Ying Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as the “Company”)...
Zhitong Finance App News, Gloria Ying (06821) issued an announcement. On September 11, 2024, Gloria Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as the “Company”) received written notices from directors Zhang Da, Hong Liang, Zhang Ting, senior managers Jiang Yingwei, Chen Chaoyong, Zhou Yan, Xu Xiangke, and some core technical and business personnel (hereinafter referred to as “shareholding entities”). At the same time, in order to promote the company's continuous, stable and healthy development and maintain investors' recognition of the company's value benefits, The plan is to increase the company's A-share holdings through centralized bidding transactions. There is no fixed price or price range for this increase in holdings. The entities that increase their holdings will take the opportunity to implement plans to increase their holdings according to the company's stock price fluctuations and overall capital market trends. The specific amount of additional holdings is based on the number of shares actually increased at the end of the increase period. The size of the shares to be increased: not less than RMB 20 million. Implementation period: Within 6 months from the date of disclosure of this announcement (except for the period during which relevant regulations such as laws, regulations and Shenzhen Stock Exchange business rules do not allow an increase in holdings).
